SARS-CoV-2 Nucleocapsid Protein (6A8) Monoclonal Antibody bsm-41413M from Bioss Inc.

Product Specs
ItemSARS-CoV-2 Nucleocapsid Protein (6A8) Monoclonal Antibody
CompanyBioss Inc.
Price Pricing Info Supplier Page View Company Product Page
Catalog Numberbsm-41413M
Antibody TypePrimary Antibody
ClonalityMonoclonal
IsotypeIgG2b
ReactivityVirus
FormatAqueous buffered solution containing 0.01M PBS(pH7.4) with 0.1% Proclin300
ApplicationsWB, ELISA, FCM
HostMouse
TargetSARS-CoV-2 N protein
Conjugate/TagUnconjugated
Concentration1ug/ul
Quantity100ul
Clone6A8

Add to Compare List

Bioss Inc.

400 Trade Center, Suite 2990

Woburn, Massachusetts 01801

United States

Phone: 800.501.7654 (Toll free)
Phone: +1.781.569.5821 (International)

Email: info@biossusa.com
orders@biossusa.com
support@biossusa.com
business@biossusa.com

Company Profile

Website: www.biossusa.com

(1) Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the hostNature CommunicationsDecember 1, 2022Sissy Therese Sonnleitner, Martina Prelog, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B. C. Kopecky, Giovanni Almanzar, Stephan KoblmÃ¼ller, Christian Sturmbauer, Leonard Feist, et al.Germany), washing 3 times (wash pod, Siemens, Germany), anti-SARS-CoV-2 nucleocapsid protein IgG (Bioss bsm-41413M, dilution 1:5000) for 30 min at 37 °C), washing 3 times, adding of horseradish-peroxidase-conjugated

(2) Maintenance of neutralizing antibodies over ten months in convalescent SARS‐CoV‐2 afflicted patientsTransboundary and Emerging DiseasesMay 1, 2022Sissy Therese Sonnleitner, Martina Prelog, Bianca Jansen, Chantal Rodgarkia‐Dara, Sarah Gietl, Carmen Maria Schönegger, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Giovanni Almanzar, et al.Biosciences), washing 3× (wash pod, Siemens, Germany), anti‐SARS‐CoV‐2 nucleocapsid protein IgG (Bioss bsm‐41413M, dilution 1:5,000 for 30 min. at 37°C), washing 3×, adding of horseradish‐peroxidase‐conjugated goat

(3) Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid ProteinACS omegaOctober 5, 2021Cate DM, Bishop JD, Hsieh HV, Glukhova VA, Alonzo LF, Hermansky HG, Barrios-Lopez B, Grant BD, Anderson CE, Spencer E, et al.GMP-V-2019nCoV-Nab001,Sino Biological 40143-MM08,,2.5,491 36,Bioss bsm-41411M,Sino Biological 40143-MM08,,3,309 99,Bioss bsm-41413M,Sino Biological 40143-MM08,,3.5,400.5 613,Genemedi GMP-V-2019nCoV-Nab001,Sino Biological 40143-MM05,,4,221.5 585,Genemedi

Be the First to Write a Review!

SARS-CoV-2 Nucleocapsid Protein (6A8) Monoclonal Antibody from Bioss Inc.

Bioss Inc.

Citations (3)

Reviews

SARS-CoV-2 Nucleocapsid Protein (6A8) Monoclonal Antibody from Bioss Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map